Inogen (INGN) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.96% |
| Dec 31, 2025 | -15.76% |
| Sep 30, 2025 | -3.32% |
| Jun 30, 2025 | -24.42% |
| Mar 31, 2025 | -78.64% |
| Dec 31, 2024 | -24.64% |
| Sep 30, 2024 | -15.55% |
| Jun 30, 2024 | -14.77% |
| Mar 31, 2024 | -17.06% |
| Dec 31, 2023 | -36.17% |
| Sep 30, 2023 | -15.79% |
| Jun 30, 2023 | -26.50% |
| Mar 31, 2023 | -21.30% |
| Dec 31, 2022 | -26.44% |
| Sep 30, 2022 | -20.01% |
| Jun 30, 2022 | -27.87% |
| Mar 31, 2022 | -28.04% |
| Dec 31, 2021 | 3.31% |
| Sep 30, 2021 | -19.90% |
| Jun 30, 2021 | 3.63% |
| Mar 31, 2021 | -7.29% |
| Dec 31, 2020 | -5.51% |
| Sep 30, 2020 | -18.48% |
| Jun 30, 2020 | 98.52% |
| Mar 31, 2020 | -16.76% |
| Dec 31, 2019 | 10.29% |
| Sep 30, 2019 | 43.18% |
| Jun 30, 2019 | 13.94% |
| Mar 31, 2019 | -12.96% |
| Dec 31, 2018 | 23.82% |
| Sep 30, 2018 | 13.92% |
| Jun 30, 2018 | 117.25% |
| Mar 31, 2018 | 88.30% |